报价延迟最少15分钟:2025/08/13 14:32 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.03 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.80/-3.64
|
|
企业价值
37.92M
|
| 资产负债 |
|
每股账面净值
3.03
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
1.02M
|
|
每股收益
0.00
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/13 14:32 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA. |
